343 related articles for article (PubMed ID: 36136235)
1. Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.
Lai KW; Tsai TF
Dermatol Ther (Heidelb); 2022 Nov; 12(11):2415-2452. PubMed ID: 36136235
[TBL] [Abstract][Full Text] [Related]
2. Topical immunotherapy in alopecia areata.
Singh G; Lavanya M
Int J Trichology; 2010 Jan; 2(1):36-9. PubMed ID: 21188022
[TBL] [Abstract][Full Text] [Related]
3. Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update.
Mahasaksiri T; Kositkuljorn C; Anuntrangsee T; Suchonwanit P
Drug Des Devel Ther; 2021; 15():1285-1298. PubMed ID: 33790540
[TBL] [Abstract][Full Text] [Related]
4. Topical immunotherapy in combination with anthralin in the treatment of refractory alopecia areata.
Kagami S; Kishi Y; Hino H
J Cosmet Dermatol; 2020 Sep; 19(9):2411-2414. PubMed ID: 32621407
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of alopecia areata with diphencyprone].
Suditu G; Toma A; Voiculescu M
Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):760-2. PubMed ID: 12092234
[TBL] [Abstract][Full Text] [Related]
6. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
Lee S; Kim BJ; Lee YB; Lee WS
JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
[TBL] [Abstract][Full Text] [Related]
7. Effect of topical immunotherapy with squaric acid dibutylester for alopecia areata in Japanese patients.
Sakai K; Fukushima S; Mizuhashi S; Jinnin M; Makino T; Inoue Y; Ihn H
Allergol Int; 2020 Apr; 69(2):274-278. PubMed ID: 31767273
[TBL] [Abstract][Full Text] [Related]
8. Topical Immunotherapy of Alopecia Areata: A Large Retrospective Study.
Zerbinati N; Esposito C; D'Este E; Calligaro A; Valsecchi R
Dermatol Ther (Heidelb); 2018 Mar; 8(1):101-110. PubMed ID: 29442292
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
[TBL] [Abstract][Full Text] [Related]
10. Comparative Study of Efficacy and Safety of Topical Squaric Acid Dibutylester and Diphenylcyclopropenone for the Treatment of Alopecia Areata.
Tiwary AK; Mishra DK; Chaudhary SS
N Am J Med Sci; 2016 Jun; 8(6):237-42. PubMed ID: 27500127
[TBL] [Abstract][Full Text] [Related]
11. [Pigmentation abnormalities in the course of topical immunotherapy of alopecia areata].
Valsecchi R; Pansera B; Rossi A; Cainelli T
G Ital Dermatol Venereol; 1989; 124(1-2):31-2. PubMed ID: 2527809
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic approach with squaric acid dibutylester for steroid resistant-alopecia areata incognita: A pilot study of a single center.
Starace M; Vezzoni R; Alessandrini A; Bruni F; Carpanese MA; Misciali C; Sechi A; Piraccini BM
Dermatol Ther; 2021 Sep; 34(5):e15096. PubMed ID: 34390608
[TBL] [Abstract][Full Text] [Related]
13. Topical therapy of alopecia areata with squaric acid dibutylester.
Case PC; Mitchell AJ; Swanson NA; Vanderveen EE; Ellis CN; Headington JT
J Am Acad Dermatol; 1984 Mar; 10(3):447-50. PubMed ID: 6725657
[TBL] [Abstract][Full Text] [Related]
14. Modified immunotherapy for alopecia areata.
Yoshimasu T; Furukawa F
Autoimmun Rev; 2016 Jul; 15(7):664-7. PubMed ID: 26932732
[TBL] [Abstract][Full Text] [Related]
15. Monotherapy for Alopecia Areata: A Systematic Review and Network Meta-Analysis.
Gupta AK; Carviel JL; Foley KA; Shear NH; Piraccini BM; Piguet V; Tosti A
Skin Appendage Disord; 2019 Nov; 5(6):331-337. PubMed ID: 31799258
[TBL] [Abstract][Full Text] [Related]
16. Topical immunotherapy in dermatology.
Buckley DA; du Vivier AW
Int J Clin Pract; 1999 Mar; 53(2):130-7. PubMed ID: 10344049
[TBL] [Abstract][Full Text] [Related]
17. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
Morita K; Nakamura M; Nagamachi M; Kishi T; Miyachi Y
J Dermatol; 2002 Oct; 29(10):661-4. PubMed ID: 12433000
[TBL] [Abstract][Full Text] [Related]
18. Diphencyprone in the treatment of alopecia areata.
Happle R; Hausen BM; Wiesner-Menzel L
Acta Derm Venereol; 1983; 63(1):49-52. PubMed ID: 6191489
[TBL] [Abstract][Full Text] [Related]
19. Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester.
Happle R; Kalveram KJ; Büchner U; Echternacht-Happle K; Göggelmann W; Summer KH
Dermatologica; 1980; 161(5):289-97. PubMed ID: 7439477
[TBL] [Abstract][Full Text] [Related]
20. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
Chua SH; Goh CL; Ang CB
Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
